Form 4 for CATX Perspective Therapeutics, Inc.
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-05 · accession 0001437749-22-019882 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-10 | 2022-08-05 | CATX | Streeter Jennifer | COO, VP of HR | M - OptEx | $0.33 | +22.5K | 27.9K | +414% | +$7,425 |
| D | 2022-08-10 | 2022-08-05 | CATX | Streeter Jennifer | COO, VP of HR | M - OptEx | $0.00 | -22.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | M | A | 22,500 | $0.33 | 27,940 | D | — | — | |
| 2 | Derivative | Stock Options (right to buy) | 2022-08-05 | M | D | 22,500 | $0.00 | 0 | D | $0.33 · — to 2032-07-21 | 452,500 Common Stock | (F1) 475,000 stock options were granted on 7/21/2022. 25% vested on 7/21/2022 and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2022, until fully vested. The shares exercised on 8/5/2022 represent the shares that vested on 7/21/2022. |